title: Intranasal sumatriptan for migraine in children.
abstract: OBJECTIVE
  I am seeing more and more children and adolescents with headaches that can be defined as migraine headache. I have read about intranasal sumatriptan as an abortive therapy. Is this an effective treatment?
  
  
  CONCLUSIONS
  Acute migraine headache among children and adolescents is common and treatment is challenging. Intranasal sumatriptan is a safe and mostly effective option for children and adolescents. Currently the recommended dose is 20 mg for children who weigh more than 40 kg and 10 mg for children who weigh between 20 and 39 kg. Larger trials should be conducted to overcome the limitations of small sample sizes, potential low plasma concentration, and placebo effects witnessed in studies to date.
authors.forename: Ran D
authors.initials: RD
authors.lastname: Goldman
authors.forename: Garth D
authors.initials: GD
authors.lastname: Meckler
mesh_terms: D000281:Administration, Intranasal; D000293:Adolescent; D002648:Child; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D058825:Serotonin 5-HT1 Receptor Agonists / Q000008:administration & dosage*; D018170:Sumatriptan / Q000008:administration & dosage*
chemical_list: D058825:Serotonin 5-HT1 Receptor Agonists; D018170:Sumatriptan